Indeed, expression of PD-L1 and IDO was detected to different degrees on and in all five cell lines, respectively, whereat the presence of activated PBMCs clearly enhanced the levels of PD-L1 on most tumor cell lines in contrast to the IDO expression that remained similar. The gene discussed is CD274; the disease is neoplasm.